CY1116687T1 - Παραγωγα πυραζολιου χρησιμα ως αναστολεις της συνθασης της αλδοστερονης - Google Patents

Παραγωγα πυραζολιου χρησιμα ως αναστολεις της συνθασης της αλδοστερονης

Info

Publication number
CY1116687T1
CY1116687T1 CY20151100789T CY151100789T CY1116687T1 CY 1116687 T1 CY1116687 T1 CY 1116687T1 CY 20151100789 T CY20151100789 T CY 20151100789T CY 151100789 T CY151100789 T CY 151100789T CY 1116687 T1 CY1116687 T1 CY 1116687T1
Authority
CY
Cyprus
Prior art keywords
suspensions
derivatives useful
aldosterone synthesis
pyrazolium derivatives
pyrazolium
Prior art date
Application number
CY20151100789T
Other languages
Greek (el)
English (en)
Inventor
Michael Gregory Bell
Paul J Hoogestraat
Thomas Edward Mabry
Quanrong Shen
Ana Maria Escribano
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1116687(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CY1116687T1 publication Critical patent/CY1116687T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY20151100789T 2011-06-14 2015-09-11 Παραγωγα πυραζολιου χρησιμα ως αναστολεις της συνθασης της αλδοστερονης CY1116687T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161496657P 2011-06-14 2011-06-14
US201161506349P 2011-07-11 2011-07-11
EP12727984.2A EP2721009B1 (en) 2011-06-14 2012-06-07 Pyrazole derivatives useful as aldosterone synthase inhibitors

Publications (1)

Publication Number Publication Date
CY1116687T1 true CY1116687T1 (el) 2017-03-15

Family

ID=46317515

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100789T CY1116687T1 (el) 2011-06-14 2015-09-11 Παραγωγα πυραζολιου χρησιμα ως αναστολεις της συνθασης της αλδοστερονης

Country Status (33)

Country Link
US (1) US8778984B2 (enExample)
EP (1) EP2721009B1 (enExample)
JP (1) JP5890012B2 (enExample)
KR (1) KR101555119B1 (enExample)
CN (1) CN103596930B (enExample)
AR (1) AR086665A1 (enExample)
AU (1) AU2012271023A1 (enExample)
BR (1) BR112013031873A2 (enExample)
CA (1) CA2836804C (enExample)
CL (1) CL2013003536A1 (enExample)
CO (1) CO6821955A2 (enExample)
CR (1) CR20130601A (enExample)
CY (1) CY1116687T1 (enExample)
DK (1) DK2721009T3 (enExample)
DO (1) DOP2013000284A (enExample)
EA (1) EA201391655A1 (enExample)
EC (1) ECSP13013080A (enExample)
ES (1) ES2548210T3 (enExample)
GT (1) GT201300307A (enExample)
HR (1) HRP20150939T1 (enExample)
HU (1) HUE026461T2 (enExample)
IL (1) IL229485A0 (enExample)
ME (1) ME02223B (enExample)
MX (1) MX336042B (enExample)
PE (1) PE20140606A1 (enExample)
PH (1) PH12013502597A1 (enExample)
PL (1) PL2721009T3 (enExample)
PT (1) PT2721009E (enExample)
RS (1) RS54269B1 (enExample)
SG (1) SG194822A1 (enExample)
SI (1) SI2721009T1 (enExample)
TW (1) TWI518073B (enExample)
WO (1) WO2012173849A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170253577A1 (en) 2014-07-04 2017-09-07 Japan Tobacco Inc. Method for producing indole compound
CN108586221B (zh) * 2018-06-26 2021-03-02 常州制药厂有限公司 用于制备替卡格雷的中间体及其制备方法
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165369A (en) * 1981-04-06 1982-10-12 Teijin Ltd Pyrazole derivative and its preparation
US4617307A (en) 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5057521A (en) 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
JPWO2007111175A1 (ja) 2006-03-17 2009-08-13 日本碍子株式会社 目封止ハニカム構造体の製造方法
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
CN102711916B (zh) 2010-01-14 2015-09-02 诺华股份有限公司 肾上腺激素调节剂的用途

Also Published As

Publication number Publication date
CA2836804A1 (en) 2012-12-20
AU2012271023A1 (en) 2013-11-28
ME02223B (me) 2016-02-20
MX2013014790A (es) 2014-01-24
EP2721009A1 (en) 2014-04-23
BR112013031873A2 (pt) 2016-12-13
KR20140009564A (ko) 2014-01-22
CL2013003536A1 (es) 2014-07-11
WO2012173849A1 (en) 2012-12-20
EP2721009B1 (en) 2015-08-12
PL2721009T3 (pl) 2016-01-29
KR101555119B1 (ko) 2015-09-22
CR20130601A (es) 2014-05-02
CN103596930B (zh) 2015-05-13
PH12013502597A1 (en) 2018-04-11
TW201311647A (zh) 2013-03-16
ES2548210T3 (es) 2015-10-14
JP2014517034A (ja) 2014-07-17
PT2721009E (pt) 2015-10-23
HUE026461T2 (en) 2016-05-30
DOP2013000284A (es) 2014-06-30
JP5890012B2 (ja) 2016-03-22
RS54269B1 (sr) 2016-02-29
PE20140606A1 (es) 2014-05-17
DK2721009T3 (en) 2015-10-26
CN103596930A (zh) 2014-02-19
EA201391655A1 (ru) 2014-07-30
CA2836804C (en) 2016-05-24
NZ617642A (en) 2015-11-27
HRP20150939T1 (xx) 2015-10-09
ECSP13013080A (es) 2014-01-31
MX336042B (es) 2016-01-07
TWI518073B (zh) 2016-01-21
SG194822A1 (en) 2013-12-30
CO6821955A2 (es) 2013-12-31
GT201300307A (es) 2014-11-24
US8778984B2 (en) 2014-07-15
US20120322841A1 (en) 2012-12-20
HK1193103A1 (en) 2014-09-12
IL229485A0 (en) 2014-01-30
AR086665A1 (es) 2014-01-15
SI2721009T1 (sl) 2015-10-30

Similar Documents

Publication Publication Date Title
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CY1123407T1 (el) Σταθερες υδατικες φαρμακοτεχνικες μορφες της αδαλιμουμαμπης
CY1120318T1 (el) Υποκατεστημενες βενζυλινδαζολες για χρηση ως αναστολεις κινασης bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων
EA201270149A1 (ru) Ингибиторы bace
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
CY1118004T1 (el) Αναστολεις cdk
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
CR20110028A (es) Derivados de pirimidina como inhibidores de cinasa
CY1116987T1 (el) Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
EA201590224A1 (ru) Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
EA201170227A1 (ru) Имидазолкарбоксамиды
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
EA201290642A1 (ru) Соединения и способы
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
EA201490846A1 (ru) Новые производные арилхинолина
CY1118858T1 (el) Νεα παραγωγα πυριμιδινης, παρασκευη αυτων και φαρμακευτικη χρηση αυτων ως αναστολεων φωσφορυλιωσης ακτ(ρκβ)
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
CY1116775T1 (el) Παραγωγα πυριμιδονης ως αναστολεις της ιστικης τρανσγλουταμινασης
EA201590552A1 (ru) Аминохинолины в качестве ингибиторов киназы
EA201400475A1 (ru) Способы получения новых производных бензимидазола